NCT01641185已完成2 期
Hypofractionated Ion Irradiation (Carbon Ions Versus Protons) of the Prostate
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 92
- 试验地点
- 2
- 主要终点
- proctitis and cystitis
研究概览
简要总结
The purpose of this study is to evaluate the safety and feasibility of primary hypofractionated irradiation of the prostate with carbon ions or protons using the raster scan technique.
详细描述
as published: Habl G, Hatiboglu G, Edler L, Uhl M, Krause S, Roethke M, Schlemmer HP, Hadaschik B, Debus J, Herfarth K: Ion Prostate Irradiation (IPI) - a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique. BMC cancer 2014, 14(1):202.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 40 Years 至 80 Years（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •histological proven carcinoma of the prostate with Gleason score risk of lymphe node involvement of <15% calculated by the Yale-formula; Risk [%] = [GS -5] x [PSA/3 + 1.5 x T], mit T = 0, 1, and 2 for cT1c, cT2a, und cT2b/cT2c
- •Karnofsky-Index ≥ 70%
- •age between 40 and 80 years
排除标准
- •Stadium IV (distant metastases) Lymphogenous Metastases hip replacement former irradiation of the pelvis pacemaker defibrillator
结局指标
主要结局
proctitis and cystitis
时间窗: 3 years
via incidence grade 3-4 toxicity (NCI-CTC-AE)
次要结局
- PSA-PFS(3 years)
- quality of life(3 years)
- OS(3 years)
研究者
Klaus Herfarth, MD
Prof. Dr. Herfarth
Heidelberg University
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
2 期
Ion Irradiation of Sacrococcygeal ChordomaSacral ChordomaNCT01811394Heidelberg University100
招募中
不适用
Radical Hypofractionated Radiotherapy for Localized Prostate CancerLocalized Prostate CancerNCT06325774Changhai Hospital20
已完成
2 期
Hypofractionated Radiotherapy Followed by Hypo-boost for Local Advanced NSCLCNon-small Cell Lung CancerNCT03900117Sun Yat-sen University77
已完成
2 期
Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma MultiformeGlioblastoma MultiformeNCT01209442University of Colorado, Denver30
进行中（未招募）
1 期
HYPORT: A Phase I/II Study of Hypofractionated Post-operative Radiation Therapy for Head and Neck CancerSquamous Cell Carcinoma of Head and NeckNCT04403620University of Texas Southwestern Medical Center59